Proceedings of the second international molecular pathological epidemiology (MPE) meeting

[1]  Benjamin Haibe-Kains,et al.  The molecular basis of breast cancer pathological phenotypes , 2017, The Journal of pathology.

[2]  P. Horby,et al.  CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES‐I statement): an extension of the STROBE statement , 2016, Influenza and other respiratory viruses.

[3]  Daniel Nevo,et al.  Accounting for measurement error in biomarker data and misclassification of subtypes in the analysis of tumor data , 2016, Statistics in medicine.

[4]  H. Aerts.  The Potential of Radiomic-Based Phenotyping in Precision Medicine: A Review. , 2016, JAMA oncology.

[5]  Ling Tian,et al.  Aspirin in pancreatic cancer: chemopreventive effects and therapeutic potentials. , 2016, Biochimica et biophysica acta.

[6]  David A. Drew,et al.  Regular Aspirin Use Associates With Lower Risk of Colorectal Cancers With Low Numbers of Tumor-Infiltrating Lymphocytes. , 2016, Gastroenterology.

[7]  Zachary A. Szpiech,et al.  Genetic Ancestry and Natural Selection Drive Population Differences in Immune Responses to Pathogens , 2016, Cell.

[8]  J. Kelso,et al.  Genetic Adaptation and Neandertal Admixture Shaped the Immune System of Human Populations , 2016, Cell.

[9]  W. Willett,et al.  Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States. , 2016, JAMA oncology.

[10]  Eric S. Lander,et al.  Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma , 2016, Cell reports.

[11]  T. Rebbeck,et al.  Cancer Genomics: Diversity and Disparity Across Ethnicity and Geography. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  E. Giovannucci,et al.  Marine ω-3 Polyunsaturated Fatty Acid Intake and Risk of Colorectal Cancer Characterized by Tumor-Infiltrating T Cells. , 2016, JAMA oncology.

[13]  Jeffrey A. Golden,et al.  Health Care Infrastructure for Financially Sustainable Clinical Genomics. , 2016, The Journal of molecular diagnostics : JMD.

[14]  Andrew H. Beck,et al.  Height and Body Size in Childhood, Adolescence, and Young Adulthood and Breast Cancer Risk According to Molecular Subtype in the Nurses' Health Studies , 2016, Cancer Prevention Research.

[15]  Jun S. Liu,et al.  Comprehensive analyses of tumor immunity: implications for cancer immunotherapy , 2016, Genome Biology.

[16]  Ce Zhang,et al.  Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features , 2016, Nature Communications.

[17]  J. Meyerhardt,et al.  Body mass index and risk of colorectal cancer according to tumor lymphocytic infiltrate , 2016, International journal of cancer.

[18]  Suzanne E Dahlberg,et al.  Prospective Validation of Rapid Plasma Genotyping for the Detection of EGFR and KRAS Mutations in Advanced Lung Cancer. , 2016, JAMA oncology.

[19]  T. VanderWeele,et al.  Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine , 2016, Epidemiology.

[20]  Aung Ko Win,et al.  SNP rs16906252C>T Is an Expression and Methylation Quantitative Trait Locus Associated with an Increased Risk of Developing MGMT-Methylated Colorectal Cancer , 2016, Clinical Cancer Research.

[21]  L. Alexandrov,et al.  Understanding mutagenesis through delineation of mutational signatures in human cancer. , 2016, Carcinogenesis.

[22]  P. Gibbs,et al.  Sequencing Circulating Cell-Free DNA: The Potential to Refine Precision Cancer Medicine. , 2016, Clinical chemistry.

[23]  Jun S. Liu,et al.  Landscape of tumor-infiltrating T cell repertoire of human cancers , 2016, Nature Genetics.

[24]  Mingyang Song,et al.  Tumour CD274 (PD-L1) expression and T cells in colorectal cancer , 2016, Gut.

[25]  M. Loda,et al.  Association of Prostate Cancer Risk Variants with TMPRSS2:ERG Status: Evidence for Distinct Molecular Subtypes , 2016, Cancer Epidemiology, Biomarkers & Prevention.

[26]  Molin Wang,et al.  Statistical methods for studying disease subtype heterogeneity , 2016, Statistics in medicine.

[27]  A. Bogdanov,et al.  Synthesis and Testing of Modular Dual-Modality Nanoparticles for Magnetic Resonance and Multispectral Photoacoustic Imaging. , 2016, Bioconjugate chemistry.

[28]  J. García-Foncillas,et al.  Obesity and colorectal cancer: molecular features of adipose tissue , 2016, Journal of Translational Medicine.

[29]  E. Giovannucci,et al.  Integration of molecular pathology, epidemiology and social science for global precision medicine , 2016, Expert review of molecular diagnostics.

[30]  P. Rogan,et al.  Genomic signatures for paclitaxel and gemcitabine resistance in breast cancer derived by machine learning , 2016, Molecular oncology.

[31]  John Quackenbush,et al.  Bipartite Community Structure of eQTLs , 2015, PLoS Comput. Biol..

[32]  Alexis B. Carter,et al.  Computational Pathology: A Path Ahead. , 2016, Archives of pathology & laboratory medicine.

[33]  Andrew H. Beck,et al.  Proceedings of the third international molecular pathological epidemiology (MPE) meeting , 2016, Cancer Causes & Control.

[34]  Mingyang Song,et al.  MicroRNA MIR21 and T Cells in Colorectal Cancer , 2015, Cancer Immunology Research.

[35]  J. Manson,et al.  Identification of a common variant with potential pleiotropic effect on risk of inflammatory bowel disease and colorectal cancer. , 2015, Carcinogenesis.

[36]  R. Emerson,et al.  High-throughput pairing of T cell receptor α and β sequences , 2015, Science Translational Medicine.

[37]  Franziska Michor,et al.  In situ single cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2+ breast cancer , 2015, Nature Genetics.

[38]  C. Huttenhower,et al.  Fusobacterium nucleatum and T Cells in Colorectal Carcinoma. , 2015, JAMA oncology.

[39]  S. Ogino,et al.  A Meta-Regression Method for Studying Etiological Heterogeneity Across Disease Subtypes Classified by Multiple Biomarkers. , 2015, American journal of epidemiology.

[40]  Bert Vogelstein,et al.  PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. , 2015, The New England journal of medicine.

[41]  Aung Ko Win,et al.  Association between Body Mass Index and Mortality for Colorectal Cancer Survivors: Overall and by Tumor Molecular Phenotype , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[42]  V. Seshan,et al.  Identifying Etiologically Distinct Sub-Types of Cancer: A Demonstration Project Involving Breast Cancer , 2015, Cancer medicine.

[43]  R. Emerson,et al.  High-throughput pairing of T cell receptor alpha and beta sequences (TECH2P.930) , 2015, The Journal of Immunology.

[44]  A. Chan,et al.  Nutrients, foods, and colorectal cancer prevention. , 2015, Gastroenterology.

[45]  John K. Wiencke,et al.  DNA Methylation in Whole Blood: Uses and Challenges , 2015, Current Environmental Health Reports.

[46]  Benjamin Haibe-Kains,et al.  A network model for angiogenesis in ovarian cancer , 2015, BMC Bioinformatics.

[47]  Łukasz Szylberg,et al.  Serrated Polyps and Their Alternative Pathway to the Colorectal Cancer: A Systematic Review , 2015, Gastroenterology research and practice.

[48]  Jane E. Carpenter,et al.  Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants , 2015, JNCI Journal of the National Cancer Institute.

[49]  K. McManus,et al.  Characterizing the Prevalence of Chromosome Instability in Interval Colorectal Cancer , 2015, Neoplasia.

[50]  R. Tibshirani,et al.  Molecular subtyping for clinically defined breast cancer subgroups , 2015, Breast Cancer Research.

[51]  J. Cerhan,et al.  Associations between Environmental Exposures and Incident Colorectal Cancer by ESR2 Protein Expression Level in a Population-Based Cohort of Older Women , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[52]  K. Sheahan,et al.  Estrogen Receptors and Their Implications in Colorectal Carcinogenesis , 2015, Front. Oncol..

[53]  K. Søreide,et al.  Cellular metabolism in colorectal carcinogenesis: Influence of lifestyle, gut microbiome and metabolic pathways. , 2015, Cancer letters.

[54]  Jun Yu,et al.  Promoter Hypermethylation of Tumour Suppressor Genes as Potential Biomarkers in Colorectal Cancer , 2015, International journal of molecular sciences.

[55]  E. Giovannucci,et al.  Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status , 2015, Gut.

[56]  Peter W. Laird,et al.  Association of the Colorectal CpG Island Methylator Phenotype with Molecular Features, Risk Factors, and Family History , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[57]  C. Ulrich,et al.  Translational Cancer Research: Balancing Prevention and Treatment to Combat Cancer Globally , 2014, Journal of the National Cancer Institute.

[58]  Chun Gao.  Molecular Pathological Epidemiology: An Interdisciplinary Field for Study of Hepatocellular Carcinoma , 2015 .

[59]  D. Lana.  Translational Cancer Research: Balancing Prevention and Treatment to Combat Cancer Globally , 2015 .

[60]  I. Kawachi,et al.  Lifecourse epidemiology and molecular pathological epidemiology. , 2015, American Journal of Preventive Medicine.

[61]  Andrew H. Beck,et al.  Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression , 2015, Modern Pathology.

[62]  K. Michels,et al.  Epigenetic epidemiology of cancer. , 2014, Biochemical and biophysical research communications.

[63]  S. Thibodeau,et al.  Establishment of the Cancer Prevention Study II Nutrition Cohort Colorectal Tissue Repository , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[64]  M. García-Closas,et al.  Combined associations of genetic and environmental risk factors: implications for prevention of breast cancer. , 2014, Journal of the National Cancer Institute.

[65]  F. Coppedè.  The role of epigenetics in colorectal cancer , 2014, Expert review of gastroenterology & hepatology.

[66]  Rob Knight,et al.  Advancing the Microbiome Research Community , 2014, Cell.

[67]  K. Jirström,et al.  Incident urothelial cancer in the Malmö Diet and Cancer Study: cohort characteristics and further validation of ezrin as a prognostic biomarker , 2014, Diagnostic Pathology.

[68]  R. Wolff,et al.  An analysis of genetic factors related to risk of inflammatory bowel disease and colon cancer. , 2014, Cancer epidemiology.

[69]  R. Sinha,et al.  A prospective study of serum metabolites and colorectal cancer risk , 2014, Cancer.

[70]  Gretchen L. Gierach,et al.  Terminal duct lobular unit involution of the normal breast: implications for breast cancer etiology. , 2014, Journal of the National Cancer Institute.

[71]  Kristian Cibulskis,et al.  RNF43 is frequently mutated in colorectal and endometrial cancers , 2014, Nature Genetics.

[72]  K. Lunetta,et al.  Parity, lactation, and breast cancer subtypes in African American women: results from the AMBER Consortium. , 2014, Journal of the National Cancer Institute.

[73]  Melissa A. Troester,et al.  Benign Breast Tissue Composition in Breast Cancer Patients: Association with Risk Factors, Clinical Variables, and Gene Expression , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[74]  Han Wu,et al.  Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis , 2014, Gut.

[75]  Vojtech Huser,et al.  Developing genomic knowledge bases and databases to support clinical management: current perspectives , 2014, Pharmacogenomics and personalized medicine.

[76]  Chun Jimmie Ye,et al.  Intersection of population variation and autoimmunity genetics in human T cell activation , 2014, Science.

[77]  Thomas Mikeska,et al.  DNA Methylation Biomarkers: Cancer and Beyond , 2014, Genes.

[78]  Gad Getz,et al.  Computational pathology: an emerging definition. , 2014, Archives of pathology & laboratory medicine.

[79]  D. Kerr,et al.  Are NSAIDs Coming Back to Colorectal Cancer Therapy or Not? , 2014, Current Colorectal Cancer Reports.

[80]  E. Giovannucci,et al.  Progress and Opportunities in Molecular Pathological Epidemiology of Colorectal Premalignant Lesions , 2014, The American Journal of Gastroenterology.

[81]  Dennis P. Robinson,et al.  Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project. , 2014, Journal of the National Cancer Institute. Monographs.

[82]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of gastric adenocarcinoma , 2014, Nature.

[83]  F. Farshidfar,et al.  From Genotype to Functional Phenotype: Unraveling the Metabolomic Features of Colorectal Cancer , 2014, Genes.

[84]  Seth D. Crockett,et al.  Risk Factors for Serrated Polyps of the Colorectum , 2014, Digestive Diseases and Sciences.

[85]  P. A. van den Brandt,et al.  Body Size, Physical Activity, Early-Life Energy Restriction, and Associations with Methylated Insulin-like Growth Factor–Binding Protein Genes in Colorectal Cancer , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[86]  M. Loda,et al.  Androgen Receptor CAG Repeat Polymorphism and Risk of TMPRSS2:ERG–Positive Prostate Cancer , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[87]  J. Meyerhardt,et al.  Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology , 2014, Oncogene.

[88]  Aung Ko Win,et al.  Family History of Colorectal Cancer Is Not Associated with Colorectal Cancer Survival Regardless of Microsatellite Instability Status , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[89]  R. Malekzadeh,et al.  Epidemiological transition of colorectal cancer in developing countries: environmental factors, molecular pathways, and opportunities for prevention. , 2014, World journal of gastroenterology.

[90]  P. Kuppen,et al.  Expression of HLA class I antigen, aspirin use, and survival after a diagnosis of colon cancer. , 2014, JAMA internal medicine.

[91]  E. Giovannucci,et al.  Aspirin and the Risk of Colorectal Cancer in Relation to the Expression of 15-Hydroxyprostaglandin Dehydrogenase (HPGD) , 2014, Science Translational Medicine.

[92]  A. Zullo,et al.  Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis , 2014, Tumor Biology.

[93]  N. Shaheen.  Editorial: What Is Behind the Remarkable Increase in Esophageal Adenocarcinoma? , 2014, The American Journal of Gastroenterology.

[94]  M. Toyota,et al.  Fusobacterium in colonic flora and molecular features of colorectal carcinoma. , 2014, Cancer research.

[95]  Alexander van Oudenaarden,et al.  Genetic and phenotypic diversity in breast tumor metastases. , 2014, Cancer research.

[96]  Robin L. Jones,et al.  Inference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversity. , 2014, Cell reports.

[97]  L. Eusebi,et al.  Mechanisms of obesity-induced gastrointestinal neoplasia. , 2014, Gastroenterology.

[98]  E. Giovannucci,et al.  Environmental Exposure and Tumor Heterogeneity in Colorectal Cancer Risk and Outcomes , 2014, Current Colorectal Cancer Reports.

[99]  M. Woods,et al.  Influence of pre-diagnostic cigarette smoking on colorectal cancer survival: overall and by tumour molecular phenotype , 2014, British Journal of Cancer.

[100]  S. Pocock,et al.  Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration , 2007, PLoS medicine.

[101]  Witvliet Mi.  World Health Survey: A Useful Yet Underutilized Global Health Data Source , 2014 .

[102]  Jennifer R. Rider,et al.  Circadian clock genes and risk of fatal prostate cancer , 2014, Cancer Causes & Control.

[103]  K. Jirström,et al.  Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability , 2014, BMC Cancer.

[104]  R. Irizarry,et al.  Accounting for cellular heterogeneity is critical in epigenome-wide association studies , 2014, Genome Biology.

[105]  V. Seshan,et al.  A conceptual and methodological framework for investigating etiologic heterogeneity , 2013, Statistics in medicine.

[106]  Peter Kraft,et al.  Aspirin use, 8q24 single nucleotide polymorphism rs6983267, and colorectal cancer according to CTNNB1 alterations. , 2013, Journal of the National Cancer Institute.

[107]  Jennifer R. Rider,et al.  Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG. , 2013, Journal of the National Cancer Institute.

[108]  C. Sander,et al.  An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma. , 2013, Journal of the National Cancer Institute.

[109]  F. Sinicrope,et al.  Aspirin and Colorectal Cancer: Back to the Future , 2013, Clinical Cancer Research.

[110]  D. Kerr,et al.  Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[111]  A. A. de Araújo,et al.  Lifestyle and family history influence cancer prognosis in Brazilian individuals. , 2013, Pathology, research and practice.

[112]  P. A. van den Brandt,et al.  Dietary heme iron and the risk of colorectal cancer with specific mutations in KRAS and APC. , 2013, Carcinogenesis.

[113]  S. Ogino,et al.  The merits of subtyping obesity: one size does not fit all. , 2013, JAMA.

[114]  N. Ajami,et al.  Potential role of gastrointestinal microbiota composition in prostate cancer risk , 2013, Infectious Agents and Cancer.

[115]  M. Kloor,et al.  Body Mass Index and Microsatellite Instability in Colorectal Cancer: A Population-based Study , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[116]  J. Swinnen,et al.  Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acids. , 2013, Progress in lipid research.

[117]  Nita Ahuja,et al.  The CpG island methylator phenotype: what's in a name? , 2013, Cancer research.

[118]  Reiko Nishihara,et al.  Long-term colorectal-cancer incidence and mortality after lower endoscopy. , 2013, The New England journal of medicine.

[119]  C. Carlson,et al.  Phospholipase A2G1B polymorphisms and risk of colorectal neoplasia. , 2013, International journal of molecular epidemiology and genetics.

[120]  D. Kerr,et al.  Evaluation of PIK3CA mutation as a predictor of benefit from NSAID therapy in colorectal cancer , 2013 .

[121]  M. Meyerson,et al.  Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. , 2013, Cell host & microbe.

[122]  A. Berchuck,et al.  Molecular Signatures of Epithelial Ovarian Cancer: Analysis of Associations with Tumor Characteristics and Epidemiologic Risk Factors , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[123]  F. Bazzoli,et al.  Molecular Pathways Involved in Colorectal Cancer: Implications for Disease Behavior and Prevention , 2013, International journal of molecular sciences.

[124]  N. Cho,et al.  Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location , 2013, British Journal of Cancer.

[125]  W. Willett,et al.  Breast cancer risk prediction with heterogeneous risk profiles according to breast cancer tumor markers. , 2013, American journal of epidemiology.

[126]  S. Kaufmann,et al.  Diagnostic biomarkers are hidden in the infected host’s epigenome , 2013, Expert review of molecular diagnostics.

[127]  E. Giovannucci,et al.  Original Contribution A Prospective Study of Duration of Smoking Cessation and Colorectal Cancer Risk by Epigenetics-related Tumor Classification , 2013 .

[128]  Molin Wang,et al.  Aspirin use and risk of colorectal cancer according to BRAF mutation status. , 2013, JAMA.

[129]  Kebin Liu,et al.  Epigenetics and Colorectal Cancer Pathogenesis , 2013, Cancers.

[130]  C. Huttenhower,et al.  Passing Messages between Biological Networks to Refine Predicted Interactions , 2013, PloS one.

[131]  M. Ribeiro,et al.  MGMT and MLH1 methylation in Helicobacter pylori-infected children and adults. , 2013, World journal of gastroenterology.

[132]  J. Potter,et al.  Genomic aberrations occurring in subsets of serrated colorectal lesions but not conventional adenomas. , 2013, Cancer research.

[133]  Kjetil Søreide,et al.  Molecular Pathways and Cellular Metabolism in Colorectal Cancer , 2013, Digestive Surgery.

[134]  Patrick Neven,et al.  Genome-wide association studies identify four ER negative–specific breast cancer risk loci , 2013, Nature Genetics.

[135]  Aung Ko Win,et al.  Family History of Colorectal Cancer in BRAF p.V600E-Mutated Colorectal Cancer Cases , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[136]  S. Gapstur,et al.  Associations of recreational physical activity and leisure time spent sitting with colorectal cancer survival. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[137]  W. Willett,et al.  Fruit and vegetable intake and risk of breast cancer by hormone receptor status. , 2013, Journal of the National Cancer Institute.

[138]  J. Palmer,et al.  Postpartum remodeling, lactation, and breast cancer risk: summary of a National Cancer Institute-sponsored workshop. , 2013, Journal of the National Cancer Institute.

[139]  Aung Ko Win,et al.  Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features , 2013, Modern Pathology.

[140]  Alexander Meissner,et al.  Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease , 2013, Modern Pathology.

[141]  B. Rosner,et al.  Hormonal and Reproductive Risk Factors for Epithelial Ovarian Cancer by Tumor Aggressiveness , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[142]  P. A. van den Brandt,et al.  The mTOR Pathway and the Role of Energy Balance Throughout Life in Colorectal Cancer Etiology and Prognosis: Unravelling Mechanisms Through a Multidimensional Molecular Epidemiologic Approach , 2013, Current Nutrition Reports.

[143]  Benjamin Haibe-Kains,et al.  Significance Analysis of Prognostic Signatures , 2013, PLoS Comput. Biol..

[144]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumours , 2013 .

[145]  R. Kaliaperumal,et al.  Conventional and nanotechniques for DNA methylation profiling. , 2013, The Journal of molecular diagnostics : JMD.

[146]  A. Olshan,et al.  A collaborative study of the etiology of breast cancer subtypes in African American women: the AMBER consortium , 2013, Cancer Causes & Control.

[147]  R. Schoen,et al.  MUC1 Vaccine for Individuals with Advanced Adenoma of the Colon: A Cancer Immunoprevention Feasibility Study , 2012, Cancer Prevention Research.

[148]  J. Hardwick,et al.  Cholesterol metabolism and colorectal cancers. , 2012, Current opinion in pharmacology.

[149]  T. Sellers,et al.  Integrative cancer epidemiology--the next generation. , 2012, Cancer discovery.

[150]  R. Luben,et al.  Dietary, lifestyle and clinicopathological factors associated with APC mutations and promoter methylation in colorectal cancers from the EPIC‐Norfolk study , 2012, The Journal of pathology.

[151]  Reiko Nishihara,et al.  Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. , 2012, The New England journal of medicine.

[152]  Andrew H. Beck,et al.  Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health science. , 2012, American journal of epidemiology.

[153]  F. Marincola,et al.  Cancer classification using the Immunoscore: a worldwide task force , 2012, Journal of Translational Medicine.

[154]  R. Ali,et al.  Aspirin as adjuvant therapy for colorectal cancer—reinterpreting paradigms , 2012, Nature Reviews Clinical Oncology.

[155]  Ronglai Shen,et al.  Molecular Epidemiology of EGFR and KRAS Mutations in 3,026 Lung Adenocarcinomas: Higher Susceptibility of Women to Smoking-Related KRAS-Mutant Cancers , 2012, Clinical Cancer Research.

[156]  C. Begg,et al.  Detecting and exploiting etiologic heterogeneity in epidemiologic studies. , 2012, American journal of epidemiology.

[157]  P. Lee,et al.  Systematic review with meta-analysis of the epidemiological evidence in the 1900s relating smoking to lung cancer , 2012, BMC Cancer.

[158]  M. Thun,et al.  Learning from disease heterogeneity. , 2012, The Lancet. Oncology.

[159]  Charles J. Kahi,et al.  Serrated Lesions of the Colorectum: Review and Recommendations From an Expert Panel , 2012, The American Journal of Gastroenterology.

[160]  Y. Pawitan,et al.  Gene discovery in familial cancer syndromes by exome sequencing: prospects for the elucidation of familial colorectal cancer type X , 2012, Modern Pathology.

[161]  R. Goldbohm,et al.  Body size and risk for colorectal cancers showing BRAF mutations or microsatellite instability: a pooled analysis. , 2012, International journal of epidemiology.

[162]  E. Giovannucci,et al.  Commentary: Lifestyle factors and colorectal cancer microsatellite instability--molecular pathological epidemiology science, based on unique tumour principle. , 2012, International journal of epidemiology.

[163]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.

[164]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[165]  J. Koshiol,et al.  Can tissue-based immune markers be used for studying the natural history of cancer? , 2012, Annals of epidemiology.

[166]  Shuji Ogino,et al.  How many molecular subtypes? Implications of the unique tumor principle in personalized medicine , 2012, Expert review of molecular diagnostics.

[167]  J. Ioannidis,et al.  Corrigendum to "STrengthening the Reporting of OBservational studies in Epidemiology — Molecular Epidemiology (STROBE-ME): An extension of the STROBE statement" (Prev. Med. 53 (2011) 377-387) , 2012 .

[168]  Shuji Ogino,et al.  Colorectal cancer: a tale of two sides or a continuum? , 2012, Gut.

[169]  Levi Waldron,et al.  Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum , 2012, Gut.

[170]  J. Meyerhardt,et al.  Body mass index and risk of colorectal cancer according to fatty acid synthase expression in the nurses' health study. , 2012, Journal of the National Cancer Institute.

[171]  Susan E. Clare,et al.  The Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center: A Unique Resource for Defining the “Molecular Histology” of the Breast , 2012, Cancer Prevention Research.

[172]  J. Cerhan,et al.  Postmenopausal Hormone Therapy and Colorectal Cancer Risk in Relation to Somatic KRAS Mutation Status among Older Women , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[173]  F. Grizzi,et al.  Adaptive and Innate Immunity, Non Clonal Players in Colorectal Cancer Progression , 2012 .

[174]  B. Birren,et al.  Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. , 2012, Genome research.

[175]  Paolo Vineis,et al.  STrengthening the Reporting of OBservational studies in Epidemiology--Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement. , 2011, Mutagenesis.

[176]  J. Meyerhardt,et al.  Energy in and energy out: what matters for survivors of colorectal cancer? , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[177]  P. A. van den Brandt,et al.  The CpG island methylator phenotype in colorectal cancer: progress and problems. , 2012, Biochimica et biophysica acta.

[178]  Y. Sakamoto,et al.  Pyrosequencing Assay to Measure LINE-1 Methylation Level in Esophageal Squamous Cell Carcinoma , 2012, Annals of Surgical Oncology.

[179]  Melissa A Troester,et al.  Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients , 2012, Breast Cancer Research.

[180]  王林,et al.  CONSORT , 2011 .

[181]  J. Knight,et al.  STROBE-ME - illuminating methodological issues for the reporting of molecular epidemiology data. , 2011, Preventive medicine.

[182]  William M. Grady,et al.  Epigenetics and colorectal cancer , 2011, Nature Reviews Gastroenterology &Hepatology.

[183]  J. Ioannidis,et al.  STrengthening the Reporting of OBservational studies in Epidemiology – Molecular Epidemiology (STROBE-ME): An Extension of the STROBE Statement , 2011, PLoS medicine.

[184]  C. Begg.  A strategy for distinguishing optimal cancer subtypes , 2011, International journal of cancer.

[185]  G. Dranoff,et al.  Cancer immunology—analysis of host and tumor factors for personalized medicine , 2011, Nature Reviews Clinical Oncology.

[186]  G. Getz,et al.  PathSeq: software to identify or discover microbes by deep sequencing of human tissue , 2011, Nature Biotechnology.

[187]  Martha L. Slattery,et al.  CpG Island Methylation in Colorectal Cancer: Past, Present and Future , 2011, Pathology research international.

[188]  R. Goldbohm,et al.  Body Size, Physical Activity and Risk of Colorectal Cancer with or without the CpG Island Methylator Phenotype (CIMP) , 2011, PloS one.

[189]  C. Ulrich,et al.  Nutrients in Folate-Mediated, One-Carbon Metabolism and the Risk of Rectal Tumors in Men and Women , 2011, Nutrition and cancer.

[190]  E. Giovannucci,et al.  Inflammatory markers are associated with risk of colorectal cancer and chemopreventive response to anti-inflammatory drugs. , 2011, Gastroenterology.

[191]  Mathieu Lemire,et al.  Genotype–Environment Interactions in Microsatellite Stable/Microsatellite Instability-Low Colorectal Cancer: Results from a Genome-Wide Association Study , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[192]  Victoria L. Cafourek,et al.  Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. , 2011, Journal of the National Cancer Institute.

[193]  Masahiro Tsuboi,et al.  International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[194]  G. Colditz,et al.  Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer , 2011, Breast Cancer Research and Treatment.

[195]  K. Kerlikowske,et al.  Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk , 2011, Breast Cancer Research and Treatment.

[196]  E. Giovannucci,et al.  Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field , 2010, Gut.

[197]  R. Vierkant,et al.  Independent Association of Lobular Involution and Mammographic Breast Density With Breast Cancer Risk , 2010, Journal of the National Cancer Institute.

[198]  David M. Simcha,et al.  Tackling the widespread and critical impact of batch effects in high-throughput data , 2010, Nature Reviews Genetics.

[199]  Tyler J Vanderweele,et al.  Sufficient cause interactions for categorical and ordinal exposures with three levels. , 2010, Biometrika.

[200]  N. Chatterjee,et al.  Analysis of cohort studies with multivariate and partially observed disease classification data. , 2010, Biometrika.

[201]  J. Cerhan,et al.  Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. , 2010, Journal of the National Cancer Institute.

[202]  D. Moher,et al.  CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials , 2010, PLoS medicine.

[203]  V Shane Pankratz,et al.  Association between mammographic density and age-related lobular involution of the breast. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[204]  J. Bond,et al.  CIMP Status of Interval Colon Cancers: Another Piece to the Puzzle , 2010, The American Journal of Gastroenterology.

[205]  M. García-Closas,et al.  Molecular Pathology in Epidemiologic Studies: A Primer on Key Considerations , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[206]  C. Ulrich,et al.  Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status. , 2010, Journal of the National Cancer Institute.

[207]  Shuji Ogino,et al.  Editorial Lifestyle Factors and Microsatellite Instability in Colorectal Cancer: the Evolving Field of Molecular Pathological Epidemiology , 2022 .

[208]  D. Moher,et al.  CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials , 2010, Journal of pharmacology & pharmacotherapeutics.

[209]  J. Potter,et al.  Alpha-1-antitrypsin deficiency and smoking as risk factors for mismatch repair deficient colorectal cancer: a study from the colon cancer family registry. , 2010, Molecular genetics and metabolism.

[210]  B. Rosner,et al.  Risk factors for epithelial ovarian cancer by histologic subtype. , 2010, American journal of epidemiology.

[211]  S. Ogino,et al.  Aspirin Use and Survival After Diagnosis of Colorectal Cancer , 2009 .

[212]  R. Goldbohm,et al.  Early Life Exposure to Famine and Colorectal Cancer Risk: A Role for Epigenetic Mechanisms , 2009, PloS one.

[213]  K. Straif,et al.  A review of human carcinogens--Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. , 2009, The Lancet. Oncology.

[214]  J. Potter,et al.  Associations between Smoking, Alcohol Consumption, and Colorectal Cancer, Overall and by Tumor Microsatellite Instability Status , 2009, Cancer Epidemiology, Biomarkers & Prevention.

[215]  R. Wolff,et al.  Somatic alterations, metabolizing genes and smoking in rectal cancer , 2009, International journal of cancer.

[216]  Tyler J VanderWeele,et al.  Sufficient Cause Interactions and Statistical Interactions , 2009, Epidemiology.

[217]  P. Maisonneuve,et al.  Smoking and colorectal cancer: a meta-analysis. , 2008, JAMA.

[218]  J. Chang-Claude,et al.  Physical Activity and Postmenopausal Breast Cancer: Effect Modification by Breast Cancer Subtypes and Effective Periods in Life , 2008, Cancer Epidemiology Biomarkers & Prevention.

[219]  C. Ulrich,et al.  Mismatch repair polymorphisms and risk of colon cancer, tumour microsatellite instability and interactions with lifestyle factors , 2008, Gut.

[220]  Nigam H. Shah,et al.  The Stanford Tissue Microarray Database , 2007, Nucleic Acids Res..

[221]  C. Perou,et al.  Epidemiology of basal-like breast cancer , 2008, Breast Cancer Research and Treatment.

[222]  John D Potter,et al.  Colon Cancer Family Registry: An International Resource for Studies of the Genetic Epidemiology of Colon Cancer , 2007, Cancer Epidemiology Biomarkers & Prevention.

[223]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.

[224]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, The Lancet.

[225]  M. Loda,et al.  Fatty acid synthase overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype. , 2007, Human pathology.

[226]  Shuji Ogino,et al.  Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. , 2007, The New England journal of medicine.

[227]  James M Robins,et al.  The Identification of Synergism in the Sufficient-Component-Cause Framework , 2007, Epidemiology.

[228]  M. García-Closas,et al.  Differences in Risk Factors for Breast Cancer Molecular Subtypes in a Population-Based Study , 2007, Cancer Epidemiology Biomarkers & Prevention.

[229]  J. Jass.  Classification of colorectal cancer based on correlation of clinical, morphological and molecular features , 2007, Histopathology.

[230]  Jennifer Herrick,et al.  Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer. , 2006, Journal of the National Cancer Institute.

[231]  J. Potter,et al.  Risk of microsatellite-unstable colorectal cancer is associated jointly with smoking and nonsteroidal anti-inflammatory drug use. , 2006, Cancer research.

[232]  W. Willett,et al.  Early Life Factors and Incidence of Proliferative Benign Breast Disease , 2005, Cancer Epidemiology Biomarkers & Prevention.

[233]  Graham A Colditz,et al.  Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study. , 2005, Journal of the National Cancer Institute.

[234]  Pamela Sankar,et al.  Ethnicity, Ancestry, and Race in Molecular Epidemiologic Research , 2005, Cancer Epidemiology Biomarkers & Prevention.

[235]  Christopher F. Martin,et al.  Diet, Lifestyle, and Genomic Instability in the North Carolina Colon Cancer Study , 2005, Cancer Epidemiology Biomarkers & Prevention.

[236]  Nilanjan Chatterjee,et al.  A Two-Stage Regression Model for Epidemiological Studies With Multivariate Disease Classification Data , 2004 .

[237]  M. Leppert,et al.  Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. , 2000, Journal of the National Cancer Institute.

[238]  N. Black.  CONSORT , 1996, The Lancet.

[239]  J. Hardcastle,et al.  Colorectal cancer , 1993, Europe Against Cancer European Commission Series for General Practitioners.

[240]  B S Pasternack,et al.  Risk assessment for case-control subgroups by polychotomous logistic regression. , 1986, American journal of epidemiology.

[241]  Frederick Mosteller,et al.  Reporting on methods in clinical trials. , 1982, The New England journal of medicine.